The acquisition of 3P innovation's RFF Cell enables Dalton to address larger segments of the pharmaceutical market and serve customers with greater global patient populations. TORONTO — Pharmaceutical ...

In line with Dalton's ongoing mission to adopt cutting-edge technology, this strategic investment not only expands the collaboration between the two organisations, but it also enables Toronto-based ...

Dalton Pharma Services has announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing. The expansion includes the addition of a ...

Dalton Pharma Services today announced that it has expanded it cGMP sterile powder filling capabilities as part of its ongoing focus of sterile manufacturing, supported by FedDev Ontario funding.